These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 4026268)
1. In vitro activity of cefbuperazone and other antimicrobial agents against isolates from the female genital tract. Ohm-Smith MJ; Sweet RL; Hadley WK Antimicrob Agents Chemother; 1985 Jun; 27(6):958-60. PubMed ID: 4026268 [TBL] [Abstract][Full Text] [Related]
2. In vitro activity of cefbuperazone, a new cephamycin, against anaerobic bacteria. Prabhala RH; Thadepalli H; Rao B; Bansal MB; Marshall R Antimicrob Agents Chemother; 1985 Apr; 27(4):640-2. PubMed ID: 4004195 [TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activities of BMY-28142, cefbuperazone, and cefpiramide compared with those of other cephalosporins. Khan NJ; Bihl JA; Schell RF; LeFrock JL; Weber SJ Antimicrob Agents Chemother; 1984 Oct; 26(4):585-90. PubMed ID: 6549120 [TBL] [Abstract][Full Text] [Related]
4. In vitro activity of cefbuperazone against anaerobic bacteria. Wexler H; Carter WT; Harris BH; Finegold SM Antimicrob Agents Chemother; 1985 Apr; 27(4):674-6. PubMed ID: 3847274 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of cefbuperazone compared with that of other new beta-lactam agents against anaerobic gram-negative bacilli and contribution of beta-lactamase to resistance. Del Bene VE; Carek PJ; Twitty JA; Burkey LJ Antimicrob Agents Chemother; 1985 May; 27(5):817-20. PubMed ID: 3874597 [TBL] [Abstract][Full Text] [Related]
6. BMY28142, cefbuperazone (T-1982), and Sch 34343. Antimicrobial activity against 94 anaerobes compared to seven other antimicrobial agents. Jones RN; Barry AL; Packer RR Diagn Microbiol Infect Dis; 1985 May; 3(3):263-8. PubMed ID: 3838925 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria. Shafran SD; Wong J; Chow AW Antimicrob Agents Chemother; 1985 May; 27(5):749-52. PubMed ID: 4015069 [TBL] [Abstract][Full Text] [Related]
8. The activity of cefbuperazone, a 7 alpha-methoxy 7 beta acyl ureido cephalosporin. Neu HC; Chin NX; Labthavikul P Chemioterapia; 1985 Dec; 4(6):415-23. PubMed ID: 3879464 [TBL] [Abstract][Full Text] [Related]
9. Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing. Ayers LW; Jones RN; Barry AL; Thornsberry C; Fuchs PC; Gavan TL; Gerlach EH; Sommers HM Antimicrob Agents Chemother; 1982 Nov; 22(5):859-77. PubMed ID: 6983862 [TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin. Owens WE; Finegold SM Antimicrob Agents Chemother; 1983 Apr; 23(4):626-9. PubMed ID: 6305265 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics. Perrymann F; Flournoy DJ; Qadri SM Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865 [TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals. Goldstein EJ; Citron DM Antimicrob Agents Chemother; 1985 Feb; 27(2):162-6. PubMed ID: 3985600 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibilities of anaerobic bacteria isolated from female genital tract infections. Hill GB; Ayers OM Antimicrob Agents Chemother; 1985 Mar; 27(3):324-31. PubMed ID: 3994347 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of cefotetan, a new cephamycin derivative, compared with that of other beta-lactam compounds. Wise R; Andrews JM; Hancox J Antimicrob Agents Chemother; 1982 Mar; 21(3):486-91. PubMed ID: 6954875 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity of cefotetan compared with that of other antimicrobial agents against anaerobic bacteria. Wexler HM; Finegold SM Antimicrob Agents Chemother; 1988 Apr; 32(4):601-4. PubMed ID: 3163908 [TBL] [Abstract][Full Text] [Related]
16. The in vitro activity of moxalactam against 430 clinical, bacterial isolates. Digranes A; Benonisen E; Dibb WL; Ostervold B Acta Pathol Microbiol Immunol Scand B; 1982 Feb; 90(1):69-72. PubMed ID: 6211028 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of new beta-lactam antibiotics and other antimicrobial drugs against anaerobic isolates from obstetric and gynecological infections. Ohm-Smith MJ; Hadley WK; Sweet RL Antimicrob Agents Chemother; 1982 Oct; 22(4):711-4. PubMed ID: 7181484 [TBL] [Abstract][Full Text] [Related]
18. European collaborative study of reproducibility of quantitative sensitivity testing of anaerobes. King A; Phillips I J Antimicrob Chemother; 1988 Apr; 21(4):425-38. PubMed ID: 3378957 [TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of the cephamycin cefotetan: an in-vitro comparison with other beta-lactam antibiotics. Clarke AM; Zemcov SJ J Antimicrob Chemother; 1983 Jan; 11 Suppl():67-72. PubMed ID: 6404881 [TBL] [Abstract][Full Text] [Related]
20. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin. Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]